Dynamk Capital

Northzone is a European early-stage venture capital fund that invests in innovative consumer and enterprise companies in Europe and the US East Coast,. We invest primarily at the Series A and B stage, but selectively pursue seed investments. We have deep, long-standing technology expertise and benefit from the fact that the majority of our investment team have previously founded companies.

EQT Ventures is the venture capital arm of EQT, investing in high-growth technology companies across Europe and the US.

Versant Ventures is a venture capital fund focused on biotechnology and life sciences, with a primary focus on novel therapeutics targeting important unmet medical needs. Versant Ventures both develops its own projects, and invests in external companies. In both instances we provide the necessary funds to bring the product to launch. We have a large team of scientists, known as our Discovery Engines, which develop and validate new biological discoveries and technologies. We also invest in externally developed IP in companies throughout the United States, Canada and Europe.

Andreessen Horowitz backs bold entrepreneurs who move fast, think big, and are committed to building the next major franchises in technology. Founded by Marc Andreessen and Ben Horowitz, the firm provides entrepreneurs with access to expertise and insights in innovation, executive and technical talent, market intelligence, policy and regulatory affairs, business development, and marketing and brand-building.

Union Square Ventures is a small collegial partnership based in New York that manages over $1B across seven technology-focused venture funds. Union Square Ventures is one of the most successful venture funds in the world and has been an early-stage investor in some of America's most successful startups such as Zynga, Indeed, Tumblr, Twitter, Lending Club, Etsy, Twilio and MongoDB. USV was founded in 2003 by Fred Wilson and Brad Burnham.

GV (formerly Google Ventures) is the venture capital arm of Google (Alphabet, Inc.). GV has been investing in technology and biotechnology related companies in the life science, healthcare, artificial intelligence, robotics, transportation, cyber security, and agriculture sectors. We have a world-class team of engineers, designers, physicians, scientists, marketers, and investors who work together to provide these startups exceptional support on the road to success. We help our companies interface with Google, providing unique access to the world's best technology and talent. That said, we operate as an independent venture firm that is focused on investment returns. Today, GV has approximately $2.4bn in assets under management and looks to invest $500m per year in start ups. GV is separate to Capital G (formerly Google Capital), which invests in fewer, more mature ventures, with larger deal sizes.